The global market for Opioids was estimated to be worth US$ 10050 million in 2023 and is forecast to a readjusted size of US$ 14730 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030

Opioids - Market

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Opioids, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Opioids by region & country, by Type, and by Application.

The Opioids market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioids.

Market Segmentation

Scope of Opioids - Market Report

Report Metric	Details
Report Name	Opioids - Market
Forecasted market size in 2030	US$ 14730 million
CAGR	5.5%
Forecasted years	2024 - 2030
Segment by Type:	Oxycodone Hydromorphone Codeine Fentanyl Other
Segment by Application	Pain Relief Anesthesia Cough Suppression Diarrhea Suppression Deaddiction Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Opioids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Opioids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Opioids in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Opioids - Market size in 2030?

Ans: The Opioids - Market size in 2030 will be US$ 14730 million.

Who are the main players in the Opioids - Market report?

Ans: The main players in the Opioids - Market are Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, J&J, Endo, Pfizer, INSYS, Mylan, Hikma, Egalet

What are the Application segmentation covered in the Opioids - Market report?

Ans: The Applications covered in the Opioids - Market report are Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction, Others

What are the Type segmentation covered in the Opioids - Market report?

Ans: The Types covered in the Opioids - Market report are Oxycodone, Hydromorphone, Codeine, Fentanyl, Other

1 Market Overview

1.1 Opioids Product Introduction

1.2 Global Opioids Market Size Forecast

1.2.1 Global Opioids Sales Value (2019-2030)

1.2.2 Global Opioids Sales Volume (2019-2030)

1.2.3 Global Opioids Sales Price (2019-2030)

1.3 Opioids Market Trends & Drivers

1.3.1 Opioids Industry Trends

1.3.2 Opioids Market Drivers & Opportunity

1.3.3 Opioids Market Challenges

1.3.4 Opioids Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Opioids Players Revenue Ranking (2023)

2.2 Global Opioids Revenue by Company (2019-2024)

2.3 Global Opioids Players Sales Volume Ranking (2023)

2.4 Global Opioids Sales Volume by Company Players (2019-2024)

2.5 Global Opioids Average Price by Company (2019-2024)

2.6 Key Manufacturers Opioids Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Opioids Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Opioids

2.9 Opioids Market Competitive Analysis

2.9.1 Opioids Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Opioids Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oxycodone

3.1.2 Hydromorphone

3.1.3 Codeine

3.1.4 Fentanyl

3.1.5 Other

3.2 Global Opioids Sales Value by Type

3.2.1 Global Opioids Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Opioids Sales Value, by Type (2019-2030)

3.2.3 Global Opioids Sales Value, by Type (%) (2019-2030)

3.3 Global Opioids Sales Volume by Type

3.3.1 Global Opioids Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Opioids Sales Volume, by Type (2019-2030)

3.3.3 Global Opioids Sales Volume, by Type (%) (2019-2030)

3.4 Global Opioids Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pain Relief

4.1.2 Anesthesia

4.1.3 Cough Suppression

4.1.4 Diarrhea Suppression

4.1.5 Deaddiction

4.1.6 Others

4.2 Global Opioids Sales Value by Application

4.2.1 Global Opioids Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Opioids Sales Value, by Application (2019-2030)

4.2.3 Global Opioids Sales Value, by Application (%) (2019-2030)

4.3 Global Opioids Sales Volume by Application

4.3.1 Global Opioids Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Opioids Sales Volume, by Application (2019-2030)

4.3.3 Global Opioids Sales Volume, by Application (%) (2019-2030)

4.4 Global Opioids Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Opioids Sales Value by Region

5.1.1 Global Opioids Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Opioids Sales Value by Region (2019-2024)

5.1.3 Global Opioids Sales Value by Region (2025-2030)

5.1.4 Global Opioids Sales Value by Region (%), (2019-2030)

5.2 Global Opioids Sales Volume by Region

5.2.1 Global Opioids Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Opioids Sales Volume by Region (2019-2024)

5.2.3 Global Opioids Sales Volume by Region (2025-2030)

5.2.4 Global Opioids Sales Volume by Region (%), (2019-2030)

5.3 Global Opioids Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Opioids Sales Value, 2019-2030

5.4.2 North America Opioids Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Opioids Sales Value, 2019-2030

5.5.2 Europe Opioids Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Opioids Sales Value, 2019-2030

5.6.2 Asia Pacific Opioids Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Opioids Sales Value, 2019-2030

5.7.2 South America Opioids Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Opioids Sales Value, 2019-2030

5.8.2 Middle East & Africa Opioids Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Opioids Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Opioids Sales Value

6.2.1 Key Countries/Regions Opioids Sales Value, 2019-2030

6.2.2 Key Countries/Regions Opioids Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Opioids Sales Value, 2019-2030

6.3.2 United States Opioids Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Opioids Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Opioids Sales Value, 2019-2030

6.4.2 Europe Opioids Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Opioids Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Opioids Sales Value, 2019-2030

6.5.2 China Opioids Sales Value by Type (%), 2023 VS 2030

6.5.3 China Opioids Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Opioids Sales Value, 2019-2030

6.6.2 Japan Opioids Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Opioids Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Opioids Sales Value, 2019-2030

6.7.2 South Korea Opioids Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Opioids Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Opioids Sales Value, 2019-2030

6.8.2 Southeast Asia Opioids Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Opioids Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Opioids Sales Value, 2019-2030

6.9.2 India Opioids Sales Value by Type (%), 2023 VS 2030

6.9.3 India Opioids Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Teva

7.1.1 Teva Company Information

7.1.2 Teva Introduction and Business Overview

7.1.3 Teva Opioids Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Teva Opioids Product Offerings

7.1.5 Teva Recent Development

7.2 Purdue Pharma

7.2.1 Purdue Pharma Company Information

7.2.2 Purdue Pharma Introduction and Business Overview

7.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Purdue Pharma Opioids Product Offerings

7.2.5 Purdue Pharma Recent Development

7.3 Mallinckrodt

7.3.1 Mallinckrodt Company Information

7.3.2 Mallinckrodt Introduction and Business Overview

7.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Mallinckrodt Opioids Product Offerings

7.3.5 Mallinckrodt Recent Development

7.4 Amneal Pharma

7.4.1 Amneal Pharma Company Information

7.4.2 Amneal Pharma Introduction and Business Overview

7.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Amneal Pharma Opioids Product Offerings

7.4.5 Amneal Pharma Recent Development

7.5 Collegium

7.5.1 Collegium Company Information

7.5.2 Collegium Introduction and Business Overview

7.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Collegium Opioids Product Offerings

7.5.5 Collegium Recent Development

7.6 J&J

7.6.1 J&J Company Information

7.6.2 J&J Introduction and Business Overview

7.6.3 J&J Opioids Sales, Revenue and Gross Margin (2019-2024)

7.6.4 J&J Opioids Product Offerings

7.6.5 J&J Recent Development

7.7 Endo

7.7.1 Endo Company Information

7.7.2 Endo Introduction and Business Overview

7.7.3 Endo Opioids Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Endo Opioids Product Offerings

7.7.5 Endo Recent Development

7.8 Pfizer

7.8.1 Pfizer Company Information

7.8.2 Pfizer Introduction and Business Overview

7.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Pfizer Opioids Product Offerings

7.8.5 Pfizer Recent Development

7.9 INSYS

7.9.1 INSYS Company Information

7.9.2 INSYS Introduction and Business Overview

7.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2019-2024)

7.9.4 INSYS Opioids Product Offerings

7.9.5 INSYS Recent Development

7.10 Mylan

7.10.1 Mylan Company Information

7.10.2 Mylan Introduction and Business Overview

7.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Mylan Opioids Product Offerings

7.10.5 Mylan Recent Development

7.11 Hikma

7.11.1 Hikma Company Information

7.11.2 Hikma Introduction and Business Overview

7.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Hikma Opioids Product Offerings

7.11.5 Hikma Recent Development

7.12 Egalet

7.12.1 Egalet Company Information

7.12.2 Egalet Introduction and Business Overview

7.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Egalet Opioids Product Offerings

7.12.5 Egalet Recent Development

8 Industry Chain Analysis

8.1 Opioids Industrial Chain

8.2 Opioids Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Opioids Sales Model

8.5.2 Sales Channel

8.5.3 Opioids Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Opioids Market Trends

Table 2. Opioids Market Drivers & Opportunity

Table 3. Opioids Market Challenges

Table 4. Opioids Market Restraints

Table 5. Global Opioids Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Opioids Revenue Market Share by Company (2019-2024)

Table 7. Global Opioids Sales Volume by Company (2019-2024) & (MT)

Table 8. Global Opioids Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Opioids Price by Company (2019-2024) & (USD/Kg)

Table 10. Key Manufacturers Opioids Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Opioids Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Opioids

Table 13. Global Opioids Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Opioids Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Opioids Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Opioids Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Opioids Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Opioids Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Opioids Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)

Table 22. Global Opioids Sales Volume by Type (2019-2024) & (MT)

Table 23. Global Opioids Sales Volume by Type (2025-2030) & (MT)

Table 24. Global Opioids Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Opioids Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Opioids Price by Type (2019-2024) & (USD/Kg)

Table 27. Global Opioids Price by Type (2025-2030) & (USD/Kg)

Table 28. Global Opioids Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Opioids Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Opioids Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Opioids Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Opioids Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Opioids Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)

Table 34. Global Opioids Sales Volume by Application (2019-2024) & (MT)

Table 35. Global Opioids Sales Volume by Application (2025-2030) & (MT)

Table 36. Global Opioids Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Opioids Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Opioids Price by Application (2019-2024) & (USD/Kg)

Table 39. Global Opioids Price by Application (2025-2030) & (USD/Kg)

Table 40. Global Opioids Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Opioids Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Opioids Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Opioids Sales Value by Region (2019-2024) & (%)

Table 44. Global Opioids Sales Value by Region (2025-2030) & (%)

Table 45. Global Opioids Sales Volume by Region (MT): 2019 VS 2023 VS 2030

Table 46. Global Opioids Sales Volume by Region (2019-2024) & (MT)

Table 47. Global Opioids Sales Volume by Region (2025-2030) & (MT)

Table 48. Global Opioids Sales Volume by Region (2019-2024) & (%)

Table 49. Global Opioids Sales Volume by Region (2025-2030) & (%)

Table 50. Global Opioids Average Price by Region (2019-2024) & (USD/Kg)

Table 51. Global Opioids Average Price by Region (2025-2030) & (USD/Kg)

Table 52. Key Countries/Regions Opioids Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Opioids Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Opioids Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Opioids Sales Volume, (2019-2024) & (MT)

Table 56. Key Countries/Regions Opioids Sales Volume, (2025-2030) & (MT)

Table 57. Teva Company Information

Table 58. Teva Introduction and Business Overview

Table 59. Teva Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 60. Teva Opioids Product Offerings

Table 61. Teva Recent Development

Table 62. Purdue Pharma Company Information

Table 63. Purdue Pharma Introduction and Business Overview

Table 64. Purdue Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 65. Purdue Pharma Opioids Product Offerings

Table 66. Purdue Pharma Recent Development

Table 67. Mallinckrodt Company Information

Table 68. Mallinckrodt Introduction and Business Overview

Table 69. Mallinckrodt Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 70. Mallinckrodt Opioids Product Offerings

Table 71. Mallinckrodt Recent Development

Table 72. Amneal Pharma Company Information

Table 73. Amneal Pharma Introduction and Business Overview

Table 74. Amneal Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 75. Amneal Pharma Opioids Product Offerings

Table 76. Amneal Pharma Recent Development

Table 77. Collegium Company Information

Table 78. Collegium Introduction and Business Overview

Table 79. Collegium Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 80. Collegium Opioids Product Offerings

Table 81. Collegium Recent Development

Table 82. J&J Company Information

Table 83. J&J Introduction and Business Overview

Table 84. J&J Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 85. J&J Opioids Product Offerings

Table 86. J&J Recent Development

Table 87. Endo Company Information

Table 88. Endo Introduction and Business Overview

Table 89. Endo Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 90. Endo Opioids Product Offerings

Table 91. Endo Recent Development

Table 92. Pfizer Company Information

Table 93. Pfizer Introduction and Business Overview

Table 94. Pfizer Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 95. Pfizer Opioids Product Offerings

Table 96. Pfizer Recent Development

Table 97. INSYS Company Information

Table 98. INSYS Introduction and Business Overview

Table 99. INSYS Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 100. INSYS Opioids Product Offerings

Table 101. INSYS Recent Development

Table 102. Mylan Company Information

Table 103. Mylan Introduction and Business Overview

Table 104. Mylan Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 105. Mylan Opioids Product Offerings

Table 106. Mylan Recent Development

Table 107. Hikma Company Information

Table 108. Hikma Introduction and Business Overview

Table 109. Hikma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 110. Hikma Opioids Product Offerings

Table 111. Hikma Recent Development

Table 112. Egalet Company Information

Table 113. Egalet Introduction and Business Overview

Table 114. Egalet Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 115. Egalet Opioids Product Offerings

Table 116. Egalet Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Opioids Downstream Customers

Table 120. Opioids Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Opioids Product Picture

Figure 2. Global Opioids Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Opioids Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Opioids Sales Volume (2019-2030) & (MT)

Figure 5. Global Opioids Sales Price (2019-2030) & (USD/Kg)

Figure 6. Opioids Report Years Considered

Figure 7. Global Opioids Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Opioids Players Sales Volume Ranking (2023) & (MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Opioids Revenue in 2023

Figure 10. Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Oxycodone Picture

Figure 12. Hydromorphone Picture

Figure 13. Codeine Picture

Figure 14. Fentanyl Picture

Figure 15. Other Picture

Figure 16. Global Opioids Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Opioids Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Opioids Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)

Figure 19. Global Opioids Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Opioids Price by Type (2019-2030) & (USD/Kg)

Figure 21. Product Picture of Pain Relief

Figure 22. Product Picture of Anesthesia

Figure 23. Product Picture of Cough Suppression

Figure 24. Product Picture of Diarrhea Suppression

Figure 25. Product Picture of Deaddiction

Figure 26. Product Picture of Others

Figure 27. Global Opioids Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 28. Global Opioids Sales Value Market Share by Application, 2023 & 2030

Figure 29. Global Opioids Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)

Figure 30. Global Opioids Sales Volume Market Share by Application, 2023 & 2030

Figure 31. Global Opioids Price by Application (2019-2030) & (USD/Kg)

Figure 32. North America Opioids Sales Value (2019-2030) & (US$ Million)

Figure 33. North America Opioids Sales Value by Country (%), 2023 VS 2030

Figure 34. Europe Opioids Sales Value (2019-2030) & (US$ Million)

Figure 35. Europe Opioids Sales Value by Country (%), 2023 VS 2030

Figure 36. Asia Pacific Opioids Sales Value (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Opioids Sales Value by Country (%), 2023 VS 2030

Figure 38. South America Opioids Sales Value (2019-2030) & (US$ Million)

Figure 39. South America Opioids Sales Value by Country (%), 2023 VS 2030

Figure 40. Middle East & Africa Opioids Sales Value (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Opioids Sales Value by Country (%), 2023 VS 2030

Figure 42. Key Countries/Regions Opioids Sales Value (%), (2019-2030)

Figure 43. Key Countries/Regions Opioids Sales Volume (%), (2019-2030)

Figure 44. United States Opioids Sales Value, (2019-2030) & (US$ Million)

Figure 45. United States Opioids Sales Value by Type (%), 2023 VS 2030

Figure 46. United States Opioids Sales Value by Application (%), 2023 VS 2030

Figure 47. Europe Opioids Sales Value, (2019-2030) & (US$ Million)

Figure 48. Europe Opioids Sales Value by Type (%), 2023 VS 2030

Figure 49. Europe Opioids Sales Value by Application (%), 2023 VS 2030

Figure 50. China Opioids Sales Value, (2019-2030) & (US$ Million)

Figure 51. China Opioids Sales Value by Type (%), 2023 VS 2030

Figure 52. China Opioids Sales Value by Application (%), 2023 VS 2030

Figure 53. Japan Opioids Sales Value, (2019-2030) & (US$ Million)

Figure 54. Japan Opioids Sales Value by Type (%), 2023 VS 2030

Figure 55. Japan Opioids Sales Value by Application (%), 2023 VS 2030

Figure 56. South Korea Opioids Sales Value, (2019-2030) & (US$ Million)

Figure 57. South Korea Opioids Sales Value by Type (%), 2023 VS 2030

Figure 58. South Korea Opioids Sales Value by Application (%), 2023 VS 2030

Figure 59. Southeast Asia Opioids Sales Value, (2019-2030) & (US$ Million)

Figure 60. Southeast Asia Opioids Sales Value by Type (%), 2023 VS 2030

Figure 61. Southeast Asia Opioids Sales Value by Application (%), 2023 VS 2030

Figure 62. India Opioids Sales Value, (2019-2030) & (US$ Million)

Figure 63. India Opioids Sales Value by Type (%), 2023 VS 2030

Figure 64. India Opioids Sales Value by Application (%), 2023 VS 2030

Figure 65. Opioids Industrial Chain

Figure 66. Opioids Manufacturing Cost Structure

Figure 67. Channels of Distribution (Direct Sales, and Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions